Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Fuller, BASF Invest in Agion
September 19, 2005
| A version of this story appeared in
Volume 83, Issue 38
BASF Venture Capital and H.B. Fuller Ventures have made investments in AgION Technologies, a maker of silver zeolite antimicrobial compounds. AgION has raised $41 million from investors since its founding in 1997, and it seeks to raise $7 million more in its latest funding round, including $1.5 million each from BASF and Fuller. Representatives from both firms will join AgION's board. "We see potential for using this technology with our construction, powder coatings, and adhesives products," says Bob McGrath, managing director of Fuller Ventures.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter